4DryField PH in head and neck surgery
Part of Ear, nose & throat clinical trials.
This trial tests if 4DryField PH, a substance used to control bleeding, helps patients having head and neck surgery. It aims to see if it reduces complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a head or neck operation
- No known allergy to 4DryField
- No bleeding disorder (like hemophilia)
- No prior radiation therapy to the head or neck area
- No history of a carotid artery rupture (carotid blowout)
- Willing to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gel called 4DryField® PH to see if it helps prevent adhesions (scar-like tissue) from forming after surgery for a blocked bowel caused by previous adhesions. It might reduce future blockages.
This trial tests whether a specific way of giving fluids during surgery (called goal-directed fluid therapy) can improve recovery after head and neck cancer surgery. It involves having a small tube in your artery to closely watch your blood pressure.
This trial tests if applying RADA16, a special gel, during neck surgery helps reduce fluid drainage from the wound. It may help people with head and neck cancer who need a neck dissection.
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
This trial studies a device that delivers a special “embolic” material (often described as glue) to treat a type of abnormal connection in the brain’s blood vessels (dAVF). It may help by blocking the leaking or risky blood flow, and it will be compared against how doctors handle eligible cases with other embolic materials.
This trial tests a new minimally invasive procedure using PHIL, a liquid embolic agent, to treat chronic subdural hematoma—bleeding on the brain that develops slowly over weeks. Instead of surgery, doctors inject PHIL into the middle meningeal artery to reduce bleeding and relieve symptoms like headaches, dizziness, or weakness.
Hear when a new Head and Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.